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Abstract
Endocannabinoids have been recently appointed as interesting cosmetic actives in regulating inflammaging, a state of chronic 
low-grade inflammation, known for being involved in many senescence’s manifestations, included skin aging. The aim of this study 
was to assess the anti-inflammaging activity of a new synthetic endocannabinoid, Isopalmide®, on a reconstructed skin model, on 
which inflammaging has been reproduced through UVA radiation and light mechanical stress. We tested Isopalmide® both as a single 
active and conveyed in a cosmetic product, in comparison with Anandamide, a well-known natural endocannabinoid with anti-
inflammatory action. The anti-inflammaging activity of topically applied products has been assessed, after 6 hours of treatment post-
irradiation, through the transcriptional modification of genes involved in the NF-κB pathway and the epigenetic pathway targeting 
miRs as potential biomarkers of inflammaging:  miR-21, miR-126 and miR-146a. The results confirmed the anti-inflammatory 
action of Anandamide which inhibits NF-κB, while Isopalmide® showed its anti-inflammaging activity through the establishment 
of an inflammatory/anti-inflammatory balance by maintaining NF-κB inactive in the cytoplasm and active in the nucleus. The anti-
inflammaging activity was shown also by the cosmetic product containing Isopalmide®.
Keywords: Endocannabinoids; Inflammaging; miRNAs; 
Reconstructed Human Epidermis
Introduction
Inflammation is widely known for affecting aging processes 
and for taking part in a lot of diseases which occur during 
senescence. Although in harmful situations, such as infections, 
inflammation has a physiological function helping the body to 
react to the pathogenic agents, when the inflammatory process 
does not solve or is too excessive, it becomes detrimental for 
the organism health. In the last two decades, the concept of 
inflammaging has emerged, originated mostly from the researches 
of Claudio Franceschi and his co-workers. According to their 
studies, inflammaging, a chronic low-grade inflammation that 
manifests itself primarily with aging [1], is caused by both external 
and internal factors but the main stressors have been identified in 
the self-debris of cells since, with aging, the organisms find it more 
difficult to eliminate their metabolism products [2]. Recent studies 
carried out on centenarians, who are still healthy and without 
major diseases despite their age, have highlighted significant 
levels of pro-inflammaging markers together with a high level of 
anti-inflammatory mediators, suggesting that “aging well” is not 
related to the absence of inflammation but to a favorable balance 
between inflammatory and anti-inflammatory factors [3]. 
Cutaneous senescence is a complex phenomenon due to 
multiple intrinsic and extrinsic factors. A pivotal role in senescence 
is played by epigenetics which refers to the modifications that occur 
in DNA leading to alterations in genomic expression (phenotype) 
without changes in genomic sequences (genotype). Epigenetics’ 
regulation involves several mechanisms such as DNA methylation, 
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histone modifications and modulatory activity of miRNAs. About 
the latter, miRNAs are a class of short, endogenous, single-stranded 
RNAs that regulate gene expression [4]. They are involved in 
several processes such as immune responses, cell proliferation, 
cell death, inflammation, initiation and progression of tumors [5]. 
Many studies underline that during aging there is an increase in 
the level of miRNAs, which results in the activation of pathways 
related to inflammation and senescence, such as the NF-κB one, 
and addresses them as interesting bio-markers of these processes 
[6]. 
The skin has multiple ways to maintain its balance against 
inflammation and one of these is represented by the endocannabinoid 
system. Endocannabinoids are lipid molecules produced by the 
body in a wide array of situations: in the brain, they are largely 
known for their involvement in pain control [7]; in the skin, they 
regulate the differentiation and the production of mediators by 
various skin cells [8]. Studies in mice have reported the production 
of endocannabinoids as protective agents when an inflammatory 
skin disease occurs, supporting their involvement in the regulation 
of the cutaneous inflammation [9]. Endocannabinoids exert their 
anti-inflammatory activities mainly through the binding with their 
receptors, CB1 and CB2. The first ones are localized primarily 
in the central and peripheral nervous system, while the second 
ones are found on immune cells. In addition to these receptors, 
endocannabinoids exert their action also in a receptor-independent 
way.
In fact, Anandamide, the first natural endocannabinoid 
discovered, exerts an anti-inflammatory activity in a receptor-
independent manner by acting directly on the NF-κB pathway 
[10], which is a nuclear factor with a pivotal role in the regulation 
of several genes involved in inflammation, in cell proliferation, 
tumor development, etc. Anandamide was proved to inhibit 
NF-κB-dependent transcription by inhibiting IKK activation, 
which is responsible for the phosphorylation of IκBα, the protein 
that maintains NF-κB inactive in the cytoplasm. Moreover, 
the inhibition of NF-κB was shown also by some anandamide 
analogues, such as arvanil and olvanil [10]. Based on this evidence, 
the aim of this study was to assess the anti-inflammaging activity 
of a new synthetic endocannabinoid, Isopalmide®, in comparison 
to Anandamide, and to verify the anti-inflammaging activity 
of a cosmetic product containing Isopalmide®, using an in vitro 
reconstructed Full Thickness Skin model. 
On Phenion Skin (FT-Skin) an “inflammaging stress” model 
has been developed, mimicking a low grade of inflammation 
induced by UVA exposure associated to a light mechanical stress 
on the epidermal surface thus recapitulating both barrier function 
impairment that occurs during the aging process and dermal matrix 
damages induced by a relevant biological UVA dose. 
The anti-inflammaging activity of topically applied products 
has been assessed through the transcriptional modification of 
genes involved in the NF-κB pathway and the epigenetic pathway 
targeting miRNAs as potential biomarkers of inflammaging: in 
particular miR-21, miR-126 and miR-146a are defined as inflamm-
miRs since they target mRNA related to the NF-κB pathway [11].
The NF-κB pathway can be exemplified as follow (Figure 
1): The transcription factor NF-κB (nuclear factor kappa-light-
chain-enhancer of activated B cells) is a prominent mediator of 
inflammation which acts as a key transcriptional regulator of 
many genes coding for pro-inflammatory cytokines. NF-κB is a 
protein complex that both induces and represses gene expression 
by binding to discrete DNA sequences, known as κB elements, 
in promoters and enhancers. NF-κB complexes are retained as 
inactive forms in the cytoplasm by a family of inhibitory proteins 
known as inhibitors of NF-κB (IκBs). Activation of NF-κB 
typically involves the phosphorylation of IκB by the IκB kinase 
(IKK, CHUCK) complex, which results in IκB degradation. This 
releases NF-κB and allows the free translocation in the nucleus 
and activation of pro-inflammatory response [12].   
Figure 1: Schematic representation of the NF-kB pathway
The regulation of UVA-induced inflammation is furtherly 
actuated by epigenetic modulation via miRNA expression. 
Some miRNAs, like miR-21 and miR-126, targeting mRNAs 
belonging to the NF-κB pathway, are classifiable as senescence-
associated (SA-miRs) and inflammation-associated (inflamma-
miRs). They target the NF-κB pathway primarily through a negative 
feedback loop aimed at retaining the excessive proinflammatory 
response induced by signaling activation [13].
miRNA pathway can be summarized as follow (Figure 2): 
In particular miR-21 over expression enhances the inflammatory 
response. Furthermore, miR-21 is able to reduce the expression 
of potent human anti-inflammatory molecules such as interleukin 
(IL)- 10 and TGF-β, while miR-126 plays an important role in 
the modulation of inflammatory activity by down-regulating the 
expression of IκBα, an important inhibitor of the NF-κB signaling. 
The regulatory negative loop for inflammatory pathway switches 
off is mediated by a miR-146 gene whose expression is mediated 
by NF-κB itself. By counteracting the pro-inflammatory status 
associated with cellular senescence, miR-146a can exert anti-
inflammatory effects [14].
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Figure 2: Schematic representation of the miRNA pathway. The blue 
arrows indicate an upregulation, while the red arrows indicate a down 
regulation
Materials and Methods 
Materials
Phenion® Full Thickness Skin Model, produced by 
Henkel (Düsseldorf, Germany, diameter 1.3 cm), cultivated at 
37 °C and 5% CO2 with ALI Medium. In this model, epidermal 
keratinocytes and dermal fibroblasts (from healthy donors) form 
a multilayered skin equivalent that resembles human skin under 
culture conditions. Fibroblasts are grown in a specialized stable 
matrix that does not contract under fibroblast traction forces. 
Keratinocytes are overlaid and within a few days, they develop 
an epidermis with clearly recognizable layers. Both the epidermis 
and dermis form a physiologically functional unit: the epidermis 
produces various markers of differentiation (CK10, filaggrin, 
transglutaminase, and involucrin). The epidermal-dermal junction 
presents basal membrane proteins (laminin and collagen IV). In the 
dermal compartment, de novo synthesis of elastin and fibronectin 
has been demonstrated. The proliferative cells of the basal layer 
are identified by Ki-67 staining. This commercial model (Phenion, 
Henkel) is validated for many applications in cosmetic efficacy 
and toxicology fields. For this study, the fibroblast and the 
keratinocytes derive from the same donor (no information about 
sex and age were supplied by the producer).
Isopalmide•	 ® (Palmitoyl-N-Isopropilamide, UNIFARCO 
S.p.A.) 0.1% and 0.5% w/w in ultra-pure water.
Anandamide (Arachidonoylethanolamide, Sigma Aldrich) •	
0.5% w/w in ultra-pure water.
Ceramage•	 ® Fluid Concentrate (undisclosed formula, 
UNIFARCO S.p.A.) containing 0.5% Isopalmide®. 
Methods
 Quantitative Real-Time PCR Analysis
Quantitative analysis of gene expression by qRT-PCR was 
performed on total RNA extracted by RNAqueous kit (Ambion) 
and on miRNA extracted by mirVANA kit (Ambion) following 
the producer’s instructions. After retro transcription using the High 
Capacity kit (Invitrogen), the produced cDNA has been used for 
relative quantification PCR by using TaqMan Master Mix and gene 
assays (Invitrogen) referenced in (Table 1). 
miRNA Code
HSA-miR-21 P161018-005 H01
HSA-miR-126 P161005-020 F10
HSA-miR-146a P160919-006 C04
U18 P160831-000 H11
Genes (RNA) Code
IKK-α (CHUK) Hs00989502_m1
NF-κB Hs00765730_m1
GADPH Hs99999905_m1
Table 1: TaqMan assays used in the qRT-PCR analysis
For data analysis, the relative quantification value (RQ) was 
accepted as significant when the gene expression is “one-fold” up 
(RQ>2) or down-regulated (RQ<0.5) compared to the calibrator 
sample (RQ=1). The internal instrument level of confidence used 
is 95%. 
LDH release
A commercially available kit (Cytotoxicity Detection Kit-
LDH, Roche) was used to quantify the LDH released in culture 
media by a colorimetric assay based on formazan salt detection (λ 
492 nm with reference at 690 nm). The culture media were collected 
and analyzed following the producer’s instructions. An increase in 
the amount of dead or plasma membrane-damaged cells results in 
an increase of the LDH enzyme activity in the culture media, which 
directly correlates with the amount of formazan formed during a 
defined time period measuring the number of lysed cells.
Histo-morphological analysis
At the end of the treatment, tissues were fixed in 4% formalin 
in PBS. Samples were included in paraffin blocks and sections of 
5 μm were obtained. Slides were stained with Haematoxylin and 
Eosin following internal procedures and the histological samples 
were analyzed under bright field microscopy (20x).
Experimental design
The FT-skin models were removed from the semi-solid 
transport medium and cultivated according to the supplier’s 
instructions using the ALI® culture medium. The FT-skin tissues 
were stressed at the epidermal level by a light mechanical stress 
in order to induce a keratinocyte mediated inflammatory response. 
Light mechanical abrasion was performed abrading the surface 
with Alger brush following internal standardized procedure in 
order to activate the inflammatory response without damaging 
stratum corneum. The FT-skin models were then irradiated with 
12 J/cm2 UVA (positive control: UVA) and the formulations/
actives were topically applied (50 µL) on the epidermal surface 
for 6 hours after irradiation. At the end of the exposure the FT skin 
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models were collected and the gene expression was quantified by 
TaqMan assays for the following genes:
miRNA: miR-21, miR-126, miR-146a• 
RNA: IKK-α (CHUK), IKK-γ (IKBKG), NF-κB• 
Media were collected for toxicity evaluation by LDH release 
and tissue were fixed in 4% formalin for further histological 
evaluation.
In this study, the data of gene expression have been evaluated 
on the basis of internal validation which confirms a low variability 
of the model and a good reproducibility of irradiation protocols, 
as reported by M. Meloni et al Photochem. Photobiol. Sci., 2010, 
9, 439-447.
Results and Discussion
Quantitative real-time PCR analysis results
The miRNA and RNA gene expression was measured after 6 
hours treatment with the test items compared to the positive control 
(brushed and irradiated sample). Calibrator sample is the negative 
control, which is fixed at 1 in order to measure the expression 
of the genes. All the treated samples show an anti-inflammatory 
efficacy with different effects on miRNA and mRNA expression, 
as shown in (Figures 3 and 4).
(Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, 
RQ ≥ 2 significant up regulation)
Figure 3: miRNA gene modulation after 6 hours treatment post-
irradiation
(Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, RQ ≥ 2 significant up regulation)
Figure 4: mRNA gene modulation after 6 hours treatment post-irradiation
The predictivity of the “inflammaging stress model” 
induced by UVA, on the FT skin model, has been assessed by 
gene expression analysis in stressed (positive control) samples. As 
shown in Figures 3 and 4 the UVA induces an upregulation of miR-
21, that leads to a pro-inflammatory response by NF-κB increase. 
Moreover, the UVA is able to overexpress miR-126 which leads to 
an observed increase in NF-κB gene expression which triggers the 
inflammatory response.
Anandamide 0.5% induces an upregulation of miR-21 
that leads to a pro-inflammatory response by NF-κB increase. 
At the same time, Anandamide is able to upregulate IKBKG 
(IKK-γ) that leads to phosphorylation and degradation of IκBα 
and the consequent increase of NF-κB expression. The NF-κB 
activation (upregulation) increases the miR-146 gene, which upon 
processing down-regulates the activity of different genes (IRAK1 
and TRAF6) to reduce NF-κB activity, that remains inactive in the 
cytosol (Table 2). 
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miR-126 miR-146a miR-21 CHUK IKBKG NFKB1
UVA
2.171
± 0.000
1.518
± 0.000
4.118
± 0.000
1.206
± 0.524
1.687
± 0.089
1.948
± 0.174
Anandamide 0.5%
2.821
± 0.986
1.950
± 0.000
3.551
± 0.291
1.219
± 0.379
1.909
± 0.115
2.486
± 0.196
Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, RQ ≥ 2 significant up regulation
Table 2: miRNA and RNA gene expression after irradiation and treatment with Anandamide 0.5%
These results suggest that Anandamide 0.5% has an effect on reducing the pro-inflammatory response through negative regulatory 
feedback mediated by miR-146. In fact, as shown in (Figure 5), miR-146 is a downstream inhibitor of NF-κB: The anti-inflammaging 
effect of Isopalmide® seems to be independent of concentration since it counteracts the overexpression of miR-21 and miR-126, both at 
0.1% and 0.5% (Tables 3 and 4).
Figure 5: Schematic representation of the suggested mechanism of action of Anandamide 0.5% on miRNAs and NF-κB expression. The blue arrows 
indicate an up regulation, while the red arrows indicate a down regulation.
miR-126 miR-146a miR-21 CHUK IKBKG NFKB1
UVA
2.171
± 0.000
1.518
± 0.000
4.118
± 0.000
1.206
± 0.524
1.687
± 0.089
1.948
± 0.174
Isopalmide®0,1%
1.330
± 0.219
0.938
± 0.130
1.741
± 0.796
1.353
± 0.415
2.274
± 0.787
2.074
± 0.198
Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, RQ ≥ 2 significant up regulation
Table 3: miRNA and RNA gene expression after irradiation and treatment with Isopalmide® 0.1%
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miR-126 miR-146a miR-21 CHUK IKBKG NFKB1
UVA
2.171
± 0.000
1.518
± 0.000
4.118
± 0.000
1.206
± 0.524
1.687
± 0.089
1.948
± 0.174
Isopalmide®0,5%
1.690
± 0.231
1.331
± 0.222
1.856
± 0.152
1.897
± 0.487
1.947
± 0.156
1.960
± 0.229
Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, RQ ≥ 2 significant up regulation
Table 4: miRNA and RNA gene expression after irradiation and treatment with Isopalmide® 0.5%
By reducing miR-21 expression, Isopalmide® induces the retention of NF-κB in the cytoplasm that could lead to an anti-inflammatory 
response. On the other hand, through the blocking of miR-126Isopalmide® stimulates the IKK complex (IKBKG overexpression). At 
the considered time-point (6h treatment) Isopalmide® is able to establish an inflammatory/anti-inflammatory balance by the blocking of 
miR-21 and miR-126, indicating that it could have a precocious activity on the pathway (Figure 6): The Ceramage® Fluid Concentrate, 
which contains 0.5% of Isopalmide®, has an anti-inflammaging action mediated by IκBα inhibitory control of NF-κB.
Figure 6: Schematic representation of the suggested mechanism of action of Isopalmide® 0.1% and 0.5% on miRNAs and NF-κB expression. The blue 
arrows indicate an up regulation, while the red arrows indicate a down regulation
The Ceramage® Fluid Concentrate does not induce a significant upregulation of miR-21 and miR-126 (Table 5). 
miR-126 miR-146a miR-21 CHUK IKBKG NFKB1
UVA
2.171
± 0.000
1.518
± 0.000
4.118
± 0.000
1.206
± 0.524
1.687
± 0.089
1.948
± 0.174
Ceramage® Fluid Concentrate
1.353
± 0.384
1.237
± 0.598
1.492
± 1.045
1.116
± 0.450
1.470
± 0.185
3.592
± 0.009
Legend: RQ=1 Negative control, RQ ≤ 0.5 significant down regulation, RQ ≥ 2 significant up regulation
Table 5: miRNA and RNA gene expression after irradiation and treatment with Ceramage® Fluid Concentrate
The blocking of miR-21 induces the levels of NF-κB in the cytoplasm (inactive form), resulting in an anti-inflammatory response. 
The missing of the IKK complex activation (IKBKG and CHUK not significant expression) prevents the phosphorylation of IκBα: the 
consequence is an increase of NF-κB in the cytosol as an inactive form, resulting in an anti-inflammatory activity of Ceramage® Fluid. 
The behavior of Ceramage® Fluid Concentrate can be represented as follow (Figure 7).
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Figure 7: Schematic representation of the suggested mechanism of action 
of Ceramage® Fluid Concentrate on miRNAs and NF-κB expression. The 
blue arrows indicate an up regulation, while the red arrows indicate a 
down regulation
 LDH release and histological analysis
The results of the LDH release, after 6 hours of treatment post-
irradiation, are shown in (Figure 8).
Figure 8: LDH release in the culture media of collected samples after 6 
hours of treatment with tested compounds
Lactate dehydrogenase release in the culture medium 
was measured to quantify the membrane integrity. This enzyme 
is normally present in the cytosol and cannot be measured 
extracellularly unless cell damage has occurred. So, the release 
of LDH reflects the membrane damage and correlates to a 
toxic effect. Considering the value quantified in the control as 
the basal LDH release, an increased (3.04 fold increase) was 
observed in UVA-irradiated tissues suggesting the induction of 
the inflammaging model. After 6 hours of treatment the products 
compared to UVA-irradiated tissues induces the following results: 
Anandamide induces a decrease of LDH release (49% reduction of 
LDH release), reflecting its anti-inflammatory action; Isopalmide® 
at 0,1% does not show a difference in LDH release compared UVA 
tissues (6% decrease); Isopalmide® at 0.5% shows a lower LDH 
release compared to UVA tissues (28% of reduction); Ceramage® 
Fluid Concentrate, which contains Isopalmide® at 0.5%, induces 
a decrease of LDH release (57% reduction) reflecting its anti-
inflammatory action on the whole tissue (dermis/epidermis).
These results were also confirmed by the histology of the 
tissues treated with tested items for 6 hours post-irradiation, as 
shown in (Figure 9).
Figure 9: H&E staining histology after 6 hours treatment post-irradiation 
analysed under light microscopy (20x)
The morphology of the positive UVA-irradiated control 
appears severely modified on the dermal compartment (papillary 
upper dermis) indicating that the target of the inflammaging 
regulates skin architecture. At the epidermal level, the overall 
morphology appears not significantly modified.
In the sample treated with Anandamide 0.5%, the extracellular 
matrix of the papillary dermis appears restored and there are no 
signs of damage at the tissue level, confirming its marked anti-
inflammatory activity. The tissue treated with Ceramage® Fluid 
concentrate that contains Isopalmide® 0.5% appears even more 
restored, suggesting both an increase of the bioavailability 
of Isopalmide® by the vehicle and an additional role of other 
components of the cosmetic product. 
Conclusions
The aim of the study was to assess the activity of a new 
synthetic endocannabinoid, Isopalmide®, in comparison to a 
natural well-known endocannabinoid, anandamide. We tested the 
activity of both compounds on an in vitro skin model, previously 
validated for the expression of inflammation after irradiation with 
UVA and we evaluated the activity of anandamide and Isopalmide® 
on the NF-κB pathway, considering that in literature the effects 
of anandamide on this pathway have already been assessed 
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[10]. Given these assumptions, we observed that anandamide 
and Isopalmide® act on the NF-κB pathway in a different way: 
the first inhibits NF-κB activation through a negative regulatory 
feedback promoted by miR-146a, while the second establish an 
inflammaging/anti-inflammaging balance by the blocking of 
miRNA-21 and miRNA-126 upregulation. Moreover, we tested 
on the same model a cosmetic product containing Isopalmide® at 
0.5% and we observed an anti-inflammaging activity by preventing 
the activation of NF-κB through IKB-α inhibitory control and by 
reducing of the inflammatory miRNAs.
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